Fischer Medical Ventures has informed that pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have approved and taken on record the following at its meeting held today (24/03/2026): Pursuant to Section 203 of Companies Act, 2013 and Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Balaji Gandla (M.No:A43150) has been appointed as Company Secretary & Compliance Officer of the Company and also as Company Secretary of its Wholly Owned Subsidiary- Time Medical International Ventures (India) effective from 24/03/2026. Details with respect to Change in Key Managerial Personnel (Appointment of Company Secretary and Compliance Officer) as required under Regulation 30 read with Part A of Schedule III of the SEBI Listing Regulations and SEBI SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024, as amended is provided in Annexure to this letter. The Board Meeting commenced at 11:10 AM (IST) and concluded at 12:20 PM (IST).
The above information is a part of company’s filings submitted to BSE.
